Dimiracetam
|  | |
| Names | |
|---|---|
| IUPAC name (RS)-3,6,7,7a-Tetrahydro-1H-pyrrolo[1,5-a]imidazole-2,5-dione | |
| Identifiers | |
| 126100-97-8  | |
| ChEMBL | ChEMBL337612  | 
| ChemSpider | 59358  | 
| Jmol interactive 3D | Image Image | 
| PubChem | 65955 | 
| UNII | 4AW7F70MZO  | 
| 
 | |
| 
 | |
| Properties | |
| C6H8N2O2 | |
| Molar mass | 140.14 g·mol−1 | 
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
|  verify (what is   ?) | |
| Infobox references | |
Dimiracetam is a nootropic drug of the racetam family,[1] derivatives of which may have application in the treatment of neuropathic pain.[2]
References
- ↑ Pinza, M; Farina, C; Cerri, A; Pfeiffer, U; Riccaboni, MT; Banfi, S; Biagetti, R; Pozzi, O; et al. (1993). "Synthesis and pharmacological activity of a series of dihydro-1H-pyrrolo1,2-aimidazole-2,5(3H,6H)-diones, a novel class of potent cognition enhancers". Journal of Medicinal Chemistry 36 (26): 4214–20. doi:10.1021/jm00078a011. PMID 8277504.
- ↑ Farina, C; Gagliardi, S; Ghelardini, C; Martinelli, M; Norcini, M; Parini, C; Petrillo, P; Ronzoni, S (2008). "Synthesis and biological evaluation of novel dimiracetam derivatives useful for the treatment of neuropathic pain". Bioorganic & Medicinal Chemistry 16 (6): 3224–32. doi:10.1016/j.bmc.2007.12.015. PMID 18171618.
This article is issued from Wikipedia - version of the Monday, March 07, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.